Have you been diagnosed with moderate-to-severe plaque psoriasis?
WE ARE CONDUCTING A RESEARCH STUDY TO BETTER UNDERSTAND AND IMPROVE TREATMENT FOR HS.
If so, you may be eligible for a new clinical research study that is evaluating the safety of long-term use of deucravacitinib, an approved treatment for moderate-to-severe psoriasis.
We are looking for participants who:
- Are aged 40 years or older
- Are eligible for phototherapy (treatment that exposes your skin to certain types of ultraviolet light) or systemic treatment of psoriasis (treatment with drugs that work throughout the entire body)
- Have moderate-to-severe plaque psoriasis
- Have one or more certain cardiovascular risk factors
Please note, other criteria also apply.
<br?
Sign Up to see if you qualify